APA (7th ed.) Citation

Tagliaferri, A., Molinari, A. C., Peyvandi, F., Coppola, A., Demartis, F., Biasoli, C., . . . Castaman, G. (2023). IDEAL study: A real‐world assessment of pattern of use and clinical outcomes with recombinant coagulation factor IX albumin fusion protein (rIX‐FP) in patients with haemophilia B in Italy. Haemophilia : the official journal of the World Federation of Hemophilia, 29(1), 135-144. https://doi.org/10.1111/hae.14689

Chicago Style (17th ed.) Citation

Tagliaferri, Annarita, et al. "IDEAL Study: A Real‐world Assessment of Pattern of Use and Clinical Outcomes with Recombinant Coagulation Factor IX Albumin Fusion Protein (rIX‐FP) in Patients with Haemophilia B in Italy." Haemophilia : The Official Journal of the World Federation of Hemophilia 29, no. 1 (2023): 135-144. https://doi.org/10.1111/hae.14689.

MLA (9th ed.) Citation

Tagliaferri, Annarita, et al. "IDEAL Study: A Real‐world Assessment of Pattern of Use and Clinical Outcomes with Recombinant Coagulation Factor IX Albumin Fusion Protein (rIX‐FP) in Patients with Haemophilia B in Italy." Haemophilia : The Official Journal of the World Federation of Hemophilia, vol. 29, no. 1, 2023, pp. 135-144, https://doi.org/10.1111/hae.14689.